Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant.

Literature DB >> 17617530

Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant.

Gini F Fleming¹.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2007 PMID： 17617530 DOI： 10.1200/JCO.2007.10.8431

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.

Authors: John Moroney; Jennifer Wheler; David Hong; Aung Naing; Gerald Falchook; Diane Bodurka; Robert Coleman; Karen Lu; Lianchun Xiao; Razelle Kurzrock
Journal: Gynecol Oncol Date: 2010-03-26 Impact factor: 5.482

Review 2. New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?

Authors: Victor Rodriguez-Freixinos; Katherine Karakasis; Amit M Oza
Journal: Curr Oncol Rep Date: 2016-04 Impact factor: 5.075

Review 3. Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings.

Authors: Christine M Bestvina; Gini F Fleming
Journal: Oncologist Date: 2016-07-13

4. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.

Authors: Erica Gentilin; Mariella Minoia; Marta Bondanelli; Federico Tagliati; Ettore C Degli Uberti; Maria Chiara Zatelli
Journal: Endocrine Date: 2016-09-01 Impact factor: 3.633

5. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.

Authors: Andrea P Myers; Virginia L Filiaci; Yuping Zhang; Michael Pearl; Kian Behbakht; Vicky Makker; Parviz Hanjani; Susan Zweizig; James J Burke; Gordon Downey; Kimberly K Leslie; Paul Van Hummelen; Michael J Birrer; Gini F Fleming
Journal: Gynecol Oncol Date: 2016-04 Impact factor: 5.482

Review 6. Personalized care in uterine cancer.

Authors: David A Iglesias; Diane C Bodurka
Journal: Clin Adv Hematol Oncol Date: 2012-12

7. Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer.

Authors: Justin M Julius; Janos L Tanyi; Graciela M Nogueras-Gonzalez; Jack L Watkins; Robert L Coleman; Judith K Wolf; Judith A Smith
Journal: Int J Gynecol Cancer Date: 2013-02 Impact factor: 3.437